Evidence map›Paper›PMID 39897948›Full record

ArticleBioinformatics advances2025

Sphae: an automated toolkit for predicting phage therapy candidates from sequencing data.

Bhavya Papudeshi, Michael J Roach, Vijini Mallawaarachchi, George Bouras, Susanna R Grigson, Sarah K Giles, Clarice M Harker, Abbey L K Hutton, Anita Tarasenko, Laura K Inglis and 8 more

Abstract read
In one paragraph

Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Bioinformatics advances · 2026
    Article
  9. Article
  10. Computational function prediction of bacteria and phage proteins.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Bhavya PapudeshiFlinders Accelerator for Microbiome Exploration, College of Science of Engineering, Flinders University, Adelaide, South Australia 5042, Australia.ORCID https://orcid.org/0000-0001-5359-3100
Michael J RoachFlinders Accelerator for Microbiome Exploration, College of Science of Engineering, Flinders University, Adelaide, South Australia 5042, Australia.ORCID https://orcid.org/0000-0003-1488-5148
Vijini MallawaarachchiFlinders Accelerator for Microbiome Exploration, College of Science of Engineering, Flinders University, Adelaide, South Australia 5042, Australia.ORCID https://orcid.org/0000-0002-2651-8719
George BourasAdelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia 5070, Australia.ORCID https://orcid.org/0000-0002-5885-4186
Susanna R GrigsonFlinders Accelerator for Microbiome Exploration, College of Science of Engineering, Flinders University, Adelaide, South Australia 5042, Australia.ORCID https://orcid.org/0000-0003-4738-3451
Sarah K GilesFlinders Accelerator for Microbiome Exploration, College of Science of Engineering, Flinders University, Adelaide, South Australia 5042, Australia.ORCID https://orcid.org/0000-0002-4395-060X
Clarice M HarkerFlinders Accelerator for Microbiome Exploration, College of Science of Engineering, Flinders University, Adelaide, South Australia 5042, Australia.ORCID https://orcid.org/0009-0008-6802-6799
Abbey L K HuttonFlinders Accelerator for Microbiome Exploration, College of Science of Engineering, Flinders University, Adelaide, South Australia 5042, Australia.ORCID https://orcid.org/0000-0002-2474-1327
Anita TarasenkoFlinders Accelerator for Microbiome Exploration, College of Science of Engineering, Flinders University, Adelaide, South Australia 5042, Australia.ORCID https://orcid.org/0009-0003-4283-2374
Laura K InglisFlinders Accelerator for Microbiome Exploration, College of Science of Engineering, Flinders University, Adelaide, South Australia 5042, Australia.ORCID https://orcid.org/0000-0001-7919-8563
Alejandro A VegaDepartment of Biology, San Diego State University, San Diego, CA 92182, United States.ORCID https://orcid.org/0000-0001-9733-0468
Cole SouzaDepartment of Biology, San Diego State University, San Diego, CA 92182, United States.ORCID https://orcid.org/0009-0009-2294-0363
Lance BolingDepartment of Biology, San Diego State University, San Diego, CA 92182, United States.ORCID https://orcid.org/0009-0008-2505-4757
Hamza HajamaDepartment of Biology, San Diego State University, San Diego, CA 92182, United States.
Ana Georgina Cobián GüemesDepartment of Pathology, University of San Diego, San Diego, CA 92093-0612, United States.ORCID https://orcid.org/0000-0002-0755-5864
Anca M SegallDepartment of Biology, San Diego State University, San Diego, CA 92182, United States.ORCID https://orcid.org/0000-0002-8454-5248
Elizabeth A DinsdaleFlinders Accelerator for Microbiome Exploration, College of Science of Engineering, Flinders University, Adelaide, South Australia 5042, Australia.ORCID https://orcid.org/0000-0002-2177-203X
Robert A EdwardsFlinders Accelerator for Microbiome Exploration, College of Science of Engineering, Flinders University, Adelaide, South Australia 5042, Australia.ORCID https://orcid.org/0000-0001-8383-8949

Funding

Computational and Experimental Resources for Virome Analysis in Inflammatory Bowel Disease (CERVAID)RC2DK116713 · NIDDK · WASHINGTON UNIVERSITY · PI WANG, DAVID · 2019 to 2023
$8.9M
NIDDK NIH HHS RC2 DK116713
6 · The paper itself

Abstract

Motivation: Phage therapy offers a viable alternative for bacterial infections amid rising antimicrobial resistance. Its success relies on selecting safe and effective phage candidates that require comprehensive genomic screening to identify potential risks. However, this process is often labor intensive and time-consuming, hindering rapid clinical deployment. Results: We developed Sphae, an automated bioinformatics pipeline designed to streamline the therapeutic potential of a phage in under 10 minutes. Using Snakemake workflow manager, Sphae integrates tools for quality control, assembly, genome assessment, and annotation tailored specifically for phage biology. Sphae automates the detection of key genomic markers, including virulence factors, antimicrobial resistance genes, and lysogeny indicators such as integrase, recombinase, and transposase, which could preclude therapeutic use. Among the 65 phage sequences analyzed, 28 showed therapeutic potential, 8 failed due to low sequencing depth, 22 contained prophage or virulent markers, and 23 had multiple phage genomes. This workflow produces a report to assess phage safety and therapy suitability quickly. Sphae is scalable and portable, facilitating efficient deployment across most high-performance computing and cloud platforms, accelerating the genomic evaluation process. Availability and implementation: Sphae source code is freely available at https://github.com/linsalrob/sphae, with installation supported on Conda, PyPi, Docker containers.

Identifiers

PMID39897948
PMCPMC11783317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.